ArticleThe Journal of experimental medicine2023

PD-1 blockade and CDK4/6 inhibition augment nonoverlapping features of T cell activation in cancer.

Lestat R Ali et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.